Concepedia

Ichwaku Rastogi

IR

Statistics

Publications

3

Citations

95

H-Index

3

Active since

2015

Affiliations

Thermo Fisher Scientific (United States)(Current)

Illinois College

Ichwaku Rastogi is an author at Thermo Fisher Scientific (United States) specializing in oncogenic signaling pathways, resistance to tyrosine kinase inhibitors, and pharmacology.

ORCID

Publications per year

2015–2025

3

Publications

3

Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

Gregory M. Botting, Ichwaku Rastogi, Gagan Chhabra et al. · PLoS ONE · 2015 · 44 citations · Full text

, , +15

Mechanism of c-Met and EGFR tyrosine kinase inhibitor resistance through epithelial mesenchymal transition in non-small cell lung cancer

Ichwaku Rastogi, Supriya Rajanna, Andrew I. Webb et al. · Biochemical and Biophysical Research Communications · 2016 · 36 citations · Full text

, , +16

PD-1 blockade employed at the time CD8+ T cells are activated enhances their antitumor efficacy

Jena E. Moseman, Ichwaku Rastogi, Donghwan Jeon et al. · Journal for ImmunoTherapy of Cancer · 2025 · 15 citations · Full text

, , +17

1–3 of 3